Expanded suite of consumables, instruments and services designed to empower researchers and accelerate next-generation drug development Ninety posters and presentations at AACR powered by the Standard BioTools proteomic portfolio to advance cancer research from target discovery to clinical development SOUTH SAN FRANCISCO, Calif. -- Standard BioTools Inc. (NASDAQ: LAB) today announced the launch of new and enhanced [...]

Adds to robust offering of NGS tools enabling exome sequencing, whole genome sequencing, RNA sequencing, deep sequencing for liquid biopsy research and MRD, and methylation detection Diverse portfolio of adapter sets now includes industry leading number of unique indexes at 3,072 HT UDI Adapters Enables multiplexing and high throughput sequencing SOUTH SAN FRANCISCO, Calif. --  [...]

PORTLAND, Ore. — Araceli Biosciences, a pioneering biotechnology company revolutionizing high-content imaging and AI-powered analysis, today announced the successful completion of its Seed funding round, raising $7.2 million in new equity investment and converting $4.0 million in SAFEs, bringing total financing since Araceli’s spinout from Phoseon Technology to $11.2M. This funding will accelerate Araceli’s commercial expansion, scale manufacturing, and advance its [...]

As momentum builds, Deepcell advances commercial scale-up and market expansion for its AI-powered single cell analysis platform.  MENLO PARK, CA – Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced the appointment of Janette Phi as Chief Business and Commercial Officer. The company also completed an initial closing of a [...]

Boulder, CO – Watchmaker Genomics, a leader in high-performance genomics solutions, today announced an important milestone in providing comprehensive and robust automated solutions for next-generation sequencing (NGS) workflows. Its collaboration with Revvity has resulted in fully automated and verified methods for all of its DNA and RNA library preparation kits on the Sciclone™ G3 NGSx* liquid [...]

Latest release supports the use of MS-based purity assays from R&D through to regulated environments Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the latest release of Genedata Expressionist®, the industry-leading platform for streamlining and automating the characterization and quality monitoring of biotherapeutics using Mass Spectrometry (MS). [...]

The STCC Unified PD1/PDL1 Evaluation of Response (SUPER) study is a multi-institutional study led by STCC with the goal of identifying predictors of PD1 immunotherapy response in an Asian real-world setting, bringing together Singapore’s public healthcare and research institutions in the translational cancer research ecosystem, comprising the National Cancer Centre Singapore (NCCS), National University Cancer [...]

SINGAPORE -- GenScript Biotech Corporation, a global leader in biotechnology research services, and NSG Bio, Singapore's premier biotech incubator, today announced a strategic partnership designed to accelerate innovation and growth within the biotechnology sector. Through this partnership, GenScript will provide exclusive preferential rates along with technical guidance from experienced scientists across its extensive range of biotechnology services and [...]

SCOTTS VALLEY, Calif. -- Dovetail Genomics, a leading innovator in genomic solutions, today announced an expanded comprehensive analysis solution for somatic variation detection, addressing the challenge of identifying structural variants (SVs) using NGS platforms. The solution offers ultra-sensitive discovery of SVs at base-pair resolution down to 1% variant allele frequency (VAF), and biologically meaningful interpretation of SVs [...]

Joint grant program will provide researchers focused on emerging areas of oncology with powerful multi-omic platforms to drive new discoveries DURHAM, N.C. & FREMONT, Calif. -- BioSkryb Genomics, a pioneer in single-cell and ultra–low-input multi-omic solutions, and Ultima Genomics, a leader in scalable and cost-effective sequencing, today announced a collaboration designed to accelerate next-generation oncology research. [...]